|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Vaccine Related
|
NIAID
|
1R01AI064872-01A2
|
|
A Thermostable Measles Vaccine
|
GRIFFITHS, JEFFREY
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$577,563
|
|
Vaccine Related
|
NIAID
|
1K22AI068489-01A2
|
|
CD40L and GITRL adjuvants for adenoviral vaccines against HIV
|
STONE, GEOFFREY
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$162,000
|
|
Vaccine Related
|
NIAID
|
1K22AI073888-01
|
|
Origins of specialized Mucosal Lymphocyte Subsets and Immunoglobulin Isotypes
|
CRISCITIELLO, MICHAEL
|
TEXAS AGRILIFE RESEARCH
|
TX
|
$162,000
|
|
Vaccine Related
|
NIGMS
|
5R01GM063879-06
|
|
Expression of Human Therapeutic Proteins in Transgenic Tobacco Chloroplasts
|
DANIELL, HENRY
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$281,384
|
|
Vaccine Related
|
NCI
|
5R01CA105139-04
|
|
Dendritic Cell Vaccination During Lymphoid Reconstitution
|
WEBER, JEFFREY
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$603,745
|
|
Vaccine Related
|
NCI
|
5K08CA101954-03
|
|
Chemokine Secreting Dendritic Cells for Glioma Immunotherapy
|
SLOAN, ANDREW
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$135,426
|
|
Vaccine Related
|
NIAID
|
4R37AI040357-13
|
|
Development of VSV/HIV Recombinants as HIV Vaccines
|
ROSE, JOHN
|
YALE UNIVERSITY
|
CT
|
$330,500
|
|
Vaccine Related
|
NIAID
|
5U01AI066327-04
|
|
Rationally designed Rift Valley Fever Virus Vaccine
|
FLICK, RAMON
|
BIOPROTECTION SYSTEMS CORPORATION
|
IA
|
$462,742
|
|
Vaccine Related
|
NIDA
|
4R44DA022096-02
|
|
Development of a Micronized Needle-Free Nicotine Vaccine for Smoking Cessation an
|
SEARLES, JAMES
|
AKTIV-DRY, LLC
|
CO
|
$246,618
|
|
Vaccine Related
|
NIAID
|
4R37AI034266-13
|
|
Infant Immunoprophylaxis against a Primate Lentivirus
|
RUPRECHT, RUTH
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$820,779
|
|
Vaccine Related
|
NIDA
|
5K05DA000454-08
|
|
Comorbidity in Cocaine and Opioid Pharmacotherapy
|
KOSTEN, THOMAS
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$126,360
|
|
Vaccine Related
|
NIAID
|
5R01AI072529-02
|
|
Cellular dynamics in germinal centers during vaccination
|
NUSSENZWEIG, MICHEL
|
ROCKEFELLER UNIVERSITY
|
NY
|
$426,936
|
|
Vaccine Related
|
NIDCD
|
5R01DC007464-03
|
|
NTHi Type IV pili: expression and vaccine potential
|
MUNSON, ROBERT
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$423,695
|
|
Vaccine Related
|
NIAID
|
5R01AI057552-04
|
|
International Herpes Vaccine Project
|
KNIPE, DAVID
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$394,157
|
|
Vaccine Related
|
NCI
|
5R01CA056821-15
|
|
Immunization Against Melanoma Differentiation Antigens
|
HOUGHTON, ALAN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$294,335
|
|
Vaccine Related
|
NIAID
|
5R01AI059415-04
|
|
Endotoxin Exposure Alters-Anti-Tetanus IgE in Infants
|
OWNBY, DENNIS
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$348,515
|
|
Vaccine Related
|
NIAID
|
5R01AI042135-11
|
|
TNF Mediated Immune Defense Against Listeria Infection
|
PAMER, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$430,201
|
|
Vaccine Related
|
NIAID
|
5R01AI042023-10
|
|
Control of Paramyxovirus RNA Synthesis
|
PARKS, GRIFFITH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$233,588
|
|
Vaccine Related
|
NIAID
|
5R01AI068056-03
|
|
Generation and maintenance of influenza-specific plasma and memory B cells
|
LUND, FRANCES
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$375,067
|
|
Vaccine Related
|
NIAID
|
5R01AI067731-03
|
|
Antigen-specific CD8+ T cells and protective immunity to tuberculosis
|
BEHAR, SAMUEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$393,521
|
|
Vaccine Related
|
NIAID
|
5R01AI043603-10
|
|
Murine Memory B Cell Development and Function
|
SHLOMCHIK, MARK
|
YALE UNIVERSITY
|
CT
|
$341,772
|
|
Vaccine Related
|
NIDDK
|
1K01DK076741-01A1
|
|
Epitope sepcificity relates to GAD65-specific regulation of pathogenesis
|
DAI, YANG
|
TORREY PINES INST FOR MOLECULAR STUDIES
|
CA
|
$140,024
|
|
Vaccine Related
|
NIAID
|
5R01AI059650-05
|
|
Host response to Chlamydia genital infection in the male
|
RANK, ROGER
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
AR
|
$332,534
|
|
Vaccine Related
|
NCI
|
5R01CA077427-07
|
|
Strategies of Vaccination Against MUC.1 Antigen
|
ZANETTI, MAURIZIO
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$243,546
|
|
Vaccine Related
|
NIAID
|
5R01AI039614-12
|
|
Tracking CD4+ Memory T Cells in Vivo
|
JENKINS, MARC
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$349,557
|
|
Vaccine Related
|
NIAID
|
5R13AI065203-04
|
|
HIV DART:Frontiers in Drug Development for ARV Therapies
|
SCHINAZI, RAYMOND
|
INFORMED HORIZONS, LLC
|
GA
|
$1
|
|
Vaccine Related
|
NCI
|
5R01CA112438-03
|
|
Breaking tolerance to mEGP self-antigen
|
HERLYN, DOROTHEE
|
WISTAR INSTITUTE
|
PA
|
$197,513
|
|
Vaccine Related
|
NIAID
|
5R01AI045053-08
|
|
Recognition of bacterial antigens by NKT cells
|
KRONENBERG, MITCHELL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$361,588
|
|
Vaccine Related
|
NIAID
|
5R01AI035370-14
|
|
Human Antibodies to Cryptococcus Neoformans
|
PIROFSKI, LIISE-ANNE
|
YESHIVA UNIVERSITY
|
NY
|
$386,018
|
|
Vaccine Related
|
NIAID
|
5R01AI056070-04
|
|
Antibody Protection in Histoplamosis
|
NOSANCHUK, JOSHUA
|
YESHIVA UNIVERSITY
|
NY
|
$347,418
|
|
Vaccine Related
|
NIAID
|
5K23AI067567-03
|
|
Rebuilding immunity
|
AQUI, NICOLE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$133,029
|
|
Vaccine Related
|
NIAID
|
5R01AI020729-25
|
|
Immunoregulation in AIDS
|
LETVIN, NORMAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$658,292
|
|
Vaccine Related
|
NIAID
|
5R01AI049342-07
|
|
A Non-Human Primate Model for Cytomegalovirus Vaccines
|
BARRY, PETER
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$405,662
|
|
Vaccine Related
|
NIAID
|
5R01AI048496-07
|
|
Improved Brucella Vaccine Strains
|
FICHT, THOMAS
|
TEXAS AGRILIFE RESEARCH
|
TX
|
$346,491
|
|
Vaccine Related
|
NCI
|
5R01CA106662-04
|
|
Dendritic Cell Threapy for Cutaneous T-Cell Lymphoma
|
FALO, LOUIS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$288,651
|
|
Vaccine Related
|
NIA
|
5F32AG027641-03
|
|
Enhancing Aged CD4+ T Cell Immunity to Influenza
|
JONES, STEPHEN
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$24,853
|
|
Vaccine Related
|
NCI
|
5R01CA071669-10
|
|
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$366,750
|
|
Vaccine Related
|
NIAID
|
5R01AI069987-02
|
|
Novel HIV-1 vaccine candidates using newly transmitted clade C Envs as immunogens
|
BLACKWELL, JERRY
|
EMORY UNIVERSITY
|
GA
|
$373,025
|
|
Vaccine Related
|
NIAID
|
5R01AI054280-05
|
|
Tools for Testing HIV Immune-Control and Vaccine Models
|
WICK, W
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$169,713
|
|
Vaccine Related
|
NIAID
|
5R01AI066924-03
|
|
Novel Adenovirus Vaccine Vectors for HIV/SIV
|
BAROUCH, DAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$728,351
|
|
Vaccine Related
|
NIAID
|
5R01AI023302-22
|
|
Monoclonal Antibodies for the Study of P. carinii
|
GIGLIOTTI, FRANCIS
|
UNIVERSITY OF ROCHESTER
|
NY
|
$362,764
|
|
Vaccine Related
|
NIAID
|
5R01AI063516-03
|
|
Brucella Iron Metabolism in Host Macrophages
|
ROOP, ROY
|
EAST CAROLINA UNIVERSITY
|
NC
|
$305,412
|
|
Vaccine Related
|
NIAID
|
5R01AI036525-11
|
|
Immune Mechanisms of Protection in S Typhi Vaccines
|
SZTEIN, MARCELO
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$439,396
|
|
Vaccine Related
|
NCI
|
5R01CA105412-05
|
|
Transmembrane Proteins Involved in Human Tumor Expansion
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$331,509
|
|
Vaccine Related
|
NIAID
|
5R01AI059475-04
|
|
Functional Diversity in Pre-Immune Helper T Cells
|
MCHEYZER-WILLIAMS, MICHAEL
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$432,294
|
|
Vaccine Related
|
NCI
|
5R01CA088986-06
|
|
A fully synthetic carbohydrate-based cancer vaccine
|
BOONS, GEERT-JAN
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$338,098
|
|
Vaccine Related
|
NIAID
|
5R01AI032042-15
|
|
Methods for Evaluating Vaccine Efficacy
|
HALLORAN, M
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$438,180
|
|
Vaccine Related
|
NIAID
|
5R01AI064389-04
|
|
Identification of New Antigens for a Plague Vaccine
|
CHOPRA, ASHOK
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$351,137
|
|
Vaccine Related
|
NIAID
|
5R01AI048917-07
|
|
Virulence and Immunity to Mucoid P. aeruginosa
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$380,786
|
|
Vaccine Related
|
NIAID
|
5R01AI031940-18
|
|
Genetic Analysis of Cholera Toxin Structure and Function
|
HOLMES, RANDALL
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$562,026
|
|
Vaccine Related
|
NIAID
|
5R01AI061484-04
|
|
H2-O Mediated Antigen Focusing Modulates B Cell Immunity
|
DENZIN, LISA
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$424,620
|
|
Vaccine Related
|
NIAID
|
5R01AI067111-04
|
|
HIV-1 Glycopeptides as Immunogens
|
WANG, LAI-XI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$353,635
|
|
Vaccine Related
|
NIAID
|
5R01AI066121-02
|
|
IFNalphaBeta-Dependent and-Independent TLR/CD40 Synergy
|
KEDL, ROSS
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$377,685
|
|
Vaccine Related
|
NCI
|
5R01CA105148-04
|
|
Restoring T Cell Responses to Therapeutic Tumor Vaccines
|
FUCHS, EPHRAIM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$318,780
|
|
Vaccine Related
|
NIAID
|
5R01AI060481-05
|
|
HIV Vaccines Based on GP120-CD4 Mimetic Complexes
|
DEVICO, ANTHONY
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$345,323
|
|
Vaccine Related
|
NIAID
|
5R01AI050073-07
|
|
Regulation of T cell homeostasis by IFN-gamma
|
HARTY, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$361,744
|
|
Vaccine Related
|
NIAID
|
5R37AI030048-17
|
|
T CELL MEMORY TO VIRUSES
|
AHMED, RAFI
|
EMORY UNIVERSITY
|
GA
|
$429,930
|
|
Vaccine Related
|
NIAID
|
5R01AI044129-09
|
|
Antigen Specific MOdulation of T Cell Responses
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$305,094
|
|
Vaccine Related
|
NIMH
|
5R01MH067978-05
|
|
Maternal Viral Infection and Fetal Brain Development
|
PATTERSON, PAUL
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$307,210
|
|
Vaccine Related
|
NIAID
|
5U01AI061260-04
|
|
VSV as a vector for cytokine-assisted tularemia vaccines
|
MILLER, MARK
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$582,057
|
|
Vaccine Related
|
NIAID
|
5R01AI059635-05
|
|
Novel Dendritic Cell Chemoattractant and Receptor
|
BUTCHER, EUGENE
|
PALO ALTO INSTITUTE FOR RES & EDU, INC.
|
CA
|
$325,557
|
|
Vaccine Related
|
NIAID
|
5R01AI041636-11
|
|
Adenovirus as a Vector for Gene Therapy
|
HEARING, PATRICK
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$376,408
|
|
Vaccine Related
|
NIAID
|
5R01AI048090-07
|
|
Recognition of Mtb-infected Cells by CD8+ T Lymphocytes
|
LEWINSOHN, DAVID
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$315,746
|
|
Vaccine Related
|
NIAID
|
5R01AI020720-25
|
|
Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines
|
MILICH, DAVID
|
VACCINE RESEARCH INSTITUTE OF SAN DIEGO
|
CA
|
$747,395
|
|
Vaccine Related
|
NIAID
|
5R01AI020459-25
|
|
Varicella-Zoster Virus: T Cell/Skin Tropisms & Immunity
|
ARVIN, ANN
|
STANFORD UNIVERSITY
|
CA
|
$364,578
|
|
Vaccine Related
|
NIAID
|
5R01AI063356-04
|
|
Evaluation of Protective CMV Vaccines in Rhesus Macaques
|
BARRY, PETER
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$353,462
|
|
Vaccine Related
|
NIAID
|
5R01AI065786-02
|
|
Stable Carbohydrate Libraries in Infectious Disease
|
LINHARDT, ROBERT
|
RENSSELAER POLYTECHNIC INSTITUTE
|
NY
|
$384,618
|
|
Vaccine Related
|
NIAID
|
5R01AI058865-05
|
|
gp120 covalent analogs as candidate HIV vaccines
|
PAUL, SUDHIR
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$319,526
|
|
Vaccine Related
|
NICHD
|
5R01HD038653-07
|
|
Role of Neutralizing Antibodies in Transmission of SHIV
|
HAIGWOOD, NANCY
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$413,771
|
|
Vaccine Related
|
NIAID
|
5R01AI027811-17
|
|
Studies of Differentially Expressed Leishmania Antigens
|
MCMAHON-PRATT, DIANE
|
YALE UNIVERSITY
|
CT
|
$304,164
|
|
Vaccine Related
|
NIDCR
|
5R37DE006746-24
|
|
Antigens of Streptococcus Mutans in Caries Immunity
|
RUSSELL, MICHAEL
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$294,165
|
|
Vaccine Related
|
NIDCR
|
5R01DE013882-08
|
|
Immunomodulation by exogenous streptococcal antibody
|
BRADY, L.
|
UNIVERSITY OF FLORIDA
|
FL
|
$341,107
|
|
Vaccine Related
|
NIAID
|
5R01AI057592-05
|
|
Immune Response to P. vivax in Duffy (-) Humans
|
WANG, RUOBING
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$425,871
|
|
Vaccine Related
|
NCI
|
5R01CA058896-15
|
|
Structural Immunology of Classical and Non-classical MHC
|
WILSON, IAN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$363,853
|
|
Vaccine Related
|
NIAID
|
5R01AI058980-04
|
|
The role of MIF in hookworm infection and disease
|
CAPPELLO, MICHAEL
|
YALE UNIVERSITY
|
CT
|
$436,824
|
|
Vaccine Related
|
NCI
|
5R21CA117152-02
|
|
Vaccination With Peptide-loaded alphaDC1s For Malignant Gliomas
|
OKADA, HIDEHO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$282,150
|
|
Vaccine Related
|
NIAID
|
5R01AI054711-04
|
|
New Approaches to Schistosome vaccine antigen discovery
|
KING, CHRISTOPHER
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$385,690
|
|
Vaccine Related
|
NIAID
|
5R01AI054629-04
|
|
The role of NK cells in human M. Tuberculosis infection
|
VANKAYALAPATI, RAMAKRISHNA
|
UNIVERSITY OF TEXAS HLTH CTR AT TYLER
|
TX
|
$255,795
|
|
Vaccine Related
|
NCI
|
5R01CA111506-04
|
|
Targets of Immune-Mediated Tumor Destruction
|
DRANOFF, GLENN
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$293,631
|
|
Vaccine Related
|
NIAID
|
5R01AI067684-03
|
|
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
|
FLOMENBERG, PHYLLIS
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$297,196
|
|
Vaccine Related
|
NCI
|
7R01CA100841-03
|
|
A Novel Oncolytic HSP Vaccine for Systemic Tumor Therapy
|
HUANG, XUE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$224,748
|
|
Vaccine Related
|
NIMH
|
1R21MH083308-01
|
|
Developing appropriate risk reduction interventions for pre-teens
|
GRAY, GLENDA
|
WITS HEALTH CONSORTIUM (PTY), LTD
|
SO AFR
|
$197,003
|
|
Vaccine Related
|
NIAID
|
5R01AI057885-06
|
|
Attenuated Live and Recombinant Yersinia pestis Vaccines
|
CURTISS, ROY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$594,217
|
|
Vaccine Related
|
NIAAA
|
5R01AA011760-10
|
|
Alcohol and Reactivation TB
|
MASON, CAROL
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
LA
|
$302,944
|
|
Vaccine Related
|
NIAID
|
5U01AI069502-02
|
|
UCSF HIV Clinical Trials Unit
|
HAVLIR, DIANE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$1,028,280
|
|
Vaccine Related
|
NIAID
|
5U01AI069536-02
|
|
University of California, San Diego Clinical Trial Unit
|
SPECTOR, STEPHEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$1,127,587
|
|
Vaccine Related
|
NIAID
|
5R01AI037856-10
|
|
Mycobacterium tuberculosis Survival Regulatory Genes
|
BISHAI, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$380,205
|
|
Vaccine Related
|
NIAID
|
5R01AI065325-03
|
|
Pathogenesis of New SIVsm Lineages in Rhesus Macaques
|
APETREI, CRISTIAN
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$654,895
|
|
Vaccine Related
|
NIAID
|
5R01AI057575-05
|
|
The Role of TLR4 and RSV F Protein in Immunity to RSV
|
BLANCO, JORGE
|
VIRION SYSTEMS, INC.
|
MD
|
$495,850
|
|
Vaccine Related
|
NIAID
|
5R01AI069192-02
|
|
The Basis for MHC Class II-restricted proteasome-dependent epitopes
|
EISENLOHR, LAURENCE
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$329,586
|
|
Vaccine Related
|
NIAID
|
5R01AI067737-03
|
|
Pneumococcal immunization through a novel mechanism
|
MALLEY, RICHARD
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$402,453
|
|
Vaccine Related
|
NIAID
|
5R01AI064879-03
|
|
Nasal Vaccines: Mode of Action, Composition & Delivery
|
STAATS, HERMAN
|
DUKE UNIVERSITY
|
NC
|
$442,650
|
|
Vaccine Related
|
NIAID
|
5U01AI069419-02
|
|
Cornell Clinical Trials Unit
|
GULICK, ROY
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$1,184,443
|
|
Vaccine Related
|
NIAID
|
5R01AI057770-04
|
|
Mechanisms of Listeria-Specific Immunity
|
HILTBOLD, ELIZABETH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$360,044
|
|
Vaccine Related
|
NIAID
|
5R01AI049268-07
|
|
Glycoprotein interactions in paramyxovirus fusion
|
IORIO, RONALD
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$396,692
|
|
Vaccine Related
|
NIAID
|
5R01AI059804-05
|
|
Direct Regulation of CD8 T Cells by Interferon gamma
|
SURESH, MARULASIDDAPPA
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$270,678
|
|
Vaccine Related
|
NIAID
|
5R21AI072008-02
|
|
Packaging of Ebola Virus RNA into Budding VLPs
|
HARTY, RONALD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$193,134
|
|
Vaccine Related
|
NCI
|
5R01CA120813-02
|
|
Modulation of Microglia and T Cell Interactions in Malignant Glioma
|
HEIMBERGER, AMY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$263,340
|
|
Vaccine Related
|
NIDA
|
5F30DA022113-02
|
|
HIV Evasion of the Innate Immune Response to Retroviruses
|
ELIAS, YOUSSEF
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$36,714
|
|
Vaccine Related
|
NIA
|
5R01AG026478-02
|
|
Mechanism of Abeta Sequestration
|
TURNER, RAYMOND
|
GEORGETOWN UNIVERSITY
|
DC
|
$280,617
|
|
Vaccine Related
|
NIAID
|
5R01AI059136-05
|
|
SARS Reverse Genetics
|
BARIC, RALPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$271,608
|
|
Vaccine Related
|
NIAID
|
5R01AI069275-02
|
|
Antibody inhibition of respiratory syncytial virus G protein activity
|
TRIPP, RALPH
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$320,713
|
|
Vaccine Related
|
NCI
|
5R01CA067358-14
|
|
ENTRY MECHANISMS IN HIV-1/AIDS
|
KABAT, DAVID
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$322,145
|
|
Vaccine Related
|
NIAID
|
5R37AI041908-12
|
|
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation
|
AUGUST, J.
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$402,210
|
|
Vaccine Related
|
NIAID
|
5R01AI066992-03
|
|
Induction of HIV-specific Immune Responses
|
GANDHI, RAJESH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$550,325
|
|
Vaccine Related
|
NIAID
|
5R01AI045459-08
|
|
Variable Gene Use and Pneumococcal Immunity in AIDS
|
PIROFSKI, LIISE-ANNE
|
YESHIVA UNIVERSITY
|
NY
|
$395,309
|
|
Vaccine Related
|
NIAID
|
5R01AI058842-05
|
|
Nanoparticle HIV Protein Vaccines for Cellular Responses
|
MUMPER, RUSSELL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$279,144
|
|
Vaccine Related
|
NIAID
|
5U01AI069532-02
|
|
New York University HIV/AIDS Clinical Trial Unit
|
ABERG, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$1,488,404
|
|
Vaccine Related
|
NIAID
|
5R01AI031473-11
|
|
Impact of a new group 6 serotype on pneumococcal vaccines
|
NAHM, MOON
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$248,929
|
|
Vaccine Related
|
NIAID
|
5U01AI069474-02
|
|
The Ohio State University AIDS Clinical Trials Unit
|
KOLETAR, SUSAN
|
OHIO STATE UNIVERSITY
|
OH
|
$2,542,078
|
|
Vaccine Related
|
NIAID
|
5R01AI042815-10
|
|
Protection of Genital Mucosa and Ganglia Against HSV-2
|
MILLIGAN, GREGG
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$245,796
|
|
Vaccine Related
|
NIAID
|
5R01AI016692-28
|
|
Membrane Proteins of Treponema pallidum
|
NORGARD, MICHAEL
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$492,082
|
|
Vaccine Related
|
NIAID
|
5R01AI068413-03
|
|
A TB Vaccine for AIDS Patients
|
HORWITZ, MARCUS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$655,618
|
|
Vaccine Related
|
NIAID
|
5U01AI069418-02
|
|
Emory HIV/AIDS Clinical Trials Unit
|
LENNOX, JEFFREY
|
EMORY UNIVERSITY
|
GA
|
$3,002,959
|
|
Vaccine Related
|
OD
|
5U01AI069418-02
|
|
Emory HIV/AIDS Clinical Trials Unit
|
LENNOX, JEFFREY
|
EMORY UNIVERSITY
|
GA
|
$250,000
|
|
Vaccine Related
|
NIAID
|
5R01AI065760-03
|
|
Immune Responses to Biodefense Vaccines Early in Life
|
PASETTI, MARCELA
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$353,635
|
|
Vaccine Related
|
NIAID
|
5R01AI059118-04
|
|
Generation of Genetically Attenuated Rickettsiae
|
AZAD, ABDU
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$414,654
|
|
Vaccine Related
|
NIAID
|
5R01AI067020-02
|
|
Nucleophilic Antibodies: Characterization and Induction
|
PAUL, SUDHIR
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$437,589
|
|
Vaccine Related
|
NIDA
|
5R44DA018538-05
|
|
A Human Antibody as an Immunotherapy for Cocaine Abuse
|
NORMAN, ANDREW
|
P2D, INC.
|
OH
|
$922,721
|
|
Vaccine Related
|
NIAID
|
5R01AI061772-05
|
|
Ambient TLR Ligand Exposures and the Genesis of Asthma
|
HORNER, ANTHONY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$287,421
|
|
Vaccine Related
|
NIAID
|
5U01AI069412-02
|
|
Harvard Medical School Vaccine Clinical Trials Unit
|
DOLIN, RAPHAEL
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$977,281
|
|
Vaccine Related
|
NIAID
|
5U01AI069534-02
|
|
Penn prevention clinical trials unit
|
METZGER, DAVID
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$1,568,547
|
|
Vaccine Related
|
NIAID
|
5R01AI065967-04
|
|
Human Monoclonal Antibodies that Bind Botulinum Toxins
|
DESSAIN, SCOTT
|
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
|
PA
|
$375,096
|
|
Vaccine Related
|
NIA
|
5R01AG020159-07
|
|
Mucosal Abeta Vaccination: Modulating the Immune Response
|
LEMERE, CYNTHIA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$324,134
|
|
Vaccine Related
|
NINDS
|
5R01NS048411-04
|
|
Mechanisms of CD4+CD25+ T Regulatory Cells in EAE
|
MILLER, STEPHEN
|
NORTHWESTERN UNIVERSITY
|
IL
|
$305,492
|
|
Vaccine Related
|
NCI
|
5R01CA113576-03
|
|
Tracking Immune Activation by Stress Proteins In Vivo
|
PENNELL, CHRISTOPHER
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$252,477
|
|
Vaccine Related
|
NHLBI
|
5R01HL064715-06
|
|
Strategies for prenatal stem cell transplantation
|
FLAKE, ALAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$339,471
|
|
Vaccine Related
|
FIC
|
2K01TW006083-05A1
|
|
Genomic and immunological comparisons of M africanum and M tuberculosis
|
DE JONG, BOUKE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$119,843
|
|
Vaccine Related
|
NCI
|
5R01CA104392-05
|
|
Mechanism of Chaperone-Mediated Tumor Rejection
|
NICCHITTA, CHRISTOPHER
|
DUKE UNIVERSITY
|
NC
|
$239,473
|
|
Vaccine Related
|
NIAID
|
5R01AI063365-03
|
|
T regulatory Cells in HSV Immunity and Immunopathology
|
ROUSE, BARRY
|
UNIVERSITY OF TENNESSEE KNOXVILLE
|
TN
|
$341,670
|
|
Vaccine Related
|
NIAID
|
5R01AI062735-04
|
|
Tick polarized T-cell responses and Borrelia infection
|
WIKEL, STEPHEN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$337,184
|
|
Vaccine Related
|
NINR
|
5R01NR010004-03
|
|
HIV Testing and Women's Attitudes on HIV Vaccine Trials
|
ZIMET, GREGORY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$514,060
|
|
Vaccine Related
|
NIAID
|
5R01AI066232-04
|
|
Regulation of memory CD8 T cell development
|
KAECH, SUSAN
|
YALE UNIVERSITY
|
CT
|
$380,205
|
|
Vaccine Related
|
NIAID
|
5R13AI068368-03
|
|
2006-2008 Palm Springs Symposia on HIV/AIDS
|
ROBINSON, WILLIAM
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$15,000
|
|
Vaccine Related
|
NIAID
|
5R01AI028304-19
|
|
Development of a Vaccine for Moraxella Catarrhalis
|
MURPHY, TIMOTHY
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$293,002
|
|
Vaccine Related
|
NIAID
|
5U01AI069415-02
|
|
University of Puerto Rico Clinical Trials Unit
|
ZORRILLA, CARMEN
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$2,320,253
|
|
Vaccine Related
|
NIAID
|
5R01AI057768-04
|
|
Identification of T Cell Antigen For Q Fever Vaccination
|
SAMUEL, JAMES
|
TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
|
TX
|
$339,862
|
|
Vaccine Related
|
NIAID
|
5R01AI065779-04
|
|
Salmonella anti-influenza DNA & antigen delivery vaccine
|
CURTISS, ROY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$590,554
|
|
Vaccine Related
|
NIAID
|
5R01AI015495-26
|
|
Dietary Deficiencies and Tuberculosis Vaccine Efficacy
|
MCMURRAY, DAVID
|
TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
|
TX
|
$270,678
|
|
Vaccine Related
|
NIAID
|
5U01AI069472-02
|
|
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU
|
KURITZKES, DANIEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$3,009,817
|
|
Vaccine Related
|
NIAID
|
5U01AI065869-04
|
|
Cell responses to, and proteins exploited by, toxins
|
LORD, JOHN
|
UNIVERSITY OF WARWICK
|
UK
|
$104,680
|
|
Vaccine Related
|
NIAID
|
5R01AI055530-04
|
|
Poxvirus regulation of NF-kB: Mechanisms for virulence
|
SHISLER, JOANNA
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$297,445
|
|
Vaccine Related
|
NIAID
|
5U01AI069443-02
|
|
South-West European HIV Vaccine Clinical Trial Unit
|
PANTALEO, GIUSEPPE
|
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
|
SWITZE
|
$369,932
|
|
Vaccine Related
|
NCI
|
5R01CA120409-03
|
|
Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells
|
JUNE, CARL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$266,186
|
|
Vaccine Related
|
NIAID
|
5R01AI037584-14
|
|
Tec family tyrosine kinases in T cell signaling
|
BERG, LESLIE
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$340,093
|
|
Vaccine Related
|
NIAID
|
5U01AI069537-02
|
|
NJMS Clinical Trials Unit: Targeting Pediatric, Adolescent, and Material HIV Infe
|
OLESKE, JAMES
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$663,233
|
|
Vaccine Related
|
NIAID
|
5R01AI055710-06
|
|
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
|
BLANCHARD, THOMAS
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$177,589
|
|
Vaccine Related
|
NIAID
|
5U01AI069516-02
|
|
Western New England Maternal Pediatric Adolescent AIDS Clinical Trials Unit
|
LUZURIAGA, KATHERINE
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$741,810
|
|
Vaccine Related
|
NIAID
|
5R01AI031077-15
|
|
Protein Phosphorylation in Trypanosomes
|
PARSONS, MARILYN
|
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
|
WA
|
$454,844
|
|
Vaccine Related
|
NIAID
|
5R01AI064060-04
|
|
CTL and HIV Polymorphisms in Heterosexual Transmission
|
HUNTER, ERIC
|
EMORY UNIVERSITY
|
GA
|
$1,238,320
|
|
Vaccine Related
|
NIDCR
|
5R01DE017138-03
|
|
Oral Immunity and Adjuvant Receptors
|
HAJISHENGALLIS, GEORGIOS
|
UNIVERSITY OF LOUISVILLE
|
KY
|
$348,984
|
|
Vaccine Related
|
NCI
|
1R01CA130817-01
|
|
Interplay Between Cancer and Immune Cells on Targeted Therapy
|
LEE, PETER
|
STANFORD UNIVERSITY
|
CA
|
$435,170
|
|
Vaccine Related
|
NIAID
|
5R01AI046706-08
|
|
Poly-N-acetyl glucosamine as a vaccine for bacterial pathogens
|
PIER, GERALD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$447,179
|
|
Vaccine Related
|
NEI
|
7R01EY017373-02
|
|
Progression of Uveitis and CD8 uveitogenic T cells
|
SUN, DEMING
|
DOHENY EYE INSTITUTE
|
CA
|
$305,564
|
|
Vaccine Related
|
NIAID
|
5U13AI060000-05
|
|
Biodefense Initiative: Connecting Biodefense Community
|
LIU, MARGARET
|
KEYSTONE SYMPOSIA
|
CO
|
$9,810
|
|
Vaccine Related
|
NIAID
|
5R01AI058727-05
|
|
Augmentation of DNA Vaccine-Elicited Immunity to HIV/SIV
|
BAROUCH, DAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$369,208
|
|
Vaccine Related
|
NIAID
|
5R01AI068003-03
|
|
Novel VLP vaccines for pandemic influenza virus
|
COMPANS, RICHARD
|
EMORY UNIVERSITY
|
GA
|
$496,627
|
|
Vaccine Related
|
NIAID
|
5U01AI069554-02
|
|
Targeting High-Risk Women for HVTN and Microbicide Trials
|
NOVAK, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$596,555
|
|
Vaccine Related
|
NIAID
|
5U01AI069495-02
|
|
WASHINGTON UNIVERSITY AIDS CLINICAL TRIALS UNIT
|
CLIFFORD, DAVID
|
WASHINGTON UNIVERSITY
|
MO
|
$2,050,805
|
|
Vaccine Related
|
NIAID
|
5U01AI069423-02
|
|
University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)
|
ERON, JOSEPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$2,899,686
|
|
Vaccine Related
|
NIAID
|
5R01AI066938-03
|
|
HIV vaccine development using recombinant coxsackieviruses
|
RAMSINGH, ARLENE
|
WADSWORTH CENTER
|
NY
|
$286,186
|
|
Vaccine Related
|
NIAID
|
5U01AI069481-02
|
|
Seattle Vaccine Trials Unit
|
MCELRATH, MARGARET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$561,625
|
|
Vaccine Related
|
NIAID
|
5U01AI069470-02
|
|
Columbia Collaborative HIV/AIDS Clinical Trials Unit
|
HAMMER, SCOTT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$2,878,282
|
|
Vaccine Related
|
NIAID
|
5U01AI069511-02
|
|
Units for HIV/AIDS Clinical Trials Networks
|
KEEFER, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$2,248,523
|
|
Vaccine Related
|
NIAID
|
5U01AI069409-02
|
|
HIV/AIDS Clinical Trials in Jamaica
|
FIGUEROA, JOHN
|
JAMAICA MINISTRY OF HEALTH
|
JAMAIC
|
$461,901
|
|
Vaccine Related
|
NCI
|
5R01CA105171-05
|
|
Combining Virotherapy and Immunotherapy for Cancer
|
KASAHARA, NORIYUKI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$300,313
|
|
Vaccine Related
|
NIAID
|
5U01AI069439-02
|
|
Vanderbilt HIV Clinical Trials Unit
|
D'AQUILA, RICHARD
|
VANDERBILT UNIVERSITY
|
TN
|
$1,989,708
|
|
Vaccine Related
|
NIAID
|
5U01AI069494-02
|
|
University of Pittsburgh Clinical Trials Unit
|
MELLORS, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$2,256,665
|
|
Vaccine Related
|
NIAID
|
5U01AI069447-02
|
|
Institute of Human Virology Clinical Trials Unit
|
BLATTNER, WILLIAM
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$992,201
|
|
Vaccine Related
|
NIAID
|
5R01AI059373-04
|
|
Outer membrane lipoproteins of Borrelia burgdorferi
|
AKINS, DARRIN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$272,538
|
|
Vaccine Related
|
NIAID
|
5U01AI069452-02
|
|
Alabama-Clinical Trials Unit
|
SAAG, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$2,886,842
|
|
Vaccine Related
|
NIAID
|
5U01AI069424-02
|
|
UCLA AIDS Prevention and Treatment Clinical Trials Unit
|
CURRIER, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$2,327,803
|
|
Vaccine Related
|
NIAID
|
5R01AI064913-04
|
|
Computational tools for T- and B-cell epitope prediction
|
BRAUN, WERNER
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$280,910
|
|
Vaccine Related
|
NIAID
|
5U01AI069456-02
|
|
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
|
ESSEX, MYRON
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$2,318,432
|
|
Vaccine Related
|
NIAID
|
5R01AI059376-06
|
|
Mechanisms of Antibody-Mediated Toxin Neutralization
|
PINCUS, SETH
|
CHILDREN'S HOSPITAL (NEW ORLEANS)
|
LA
|
$290,530
|
|
Vaccine Related
|
NIAID
|
5R01AI062428-04
|
|
Antiviral CTL mobilization to the genital mucosa
|
IWASAKI, AKIKO
|
YALE UNIVERSITY
|
CT
|
$380,205
|
|
Vaccine Related
|
NIAID
|
5R01AI045025-10
|
|
Cellular Immune Surveillance of Intracellular bacteria
|
SHEN, HAO
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$313,087
|
|
Vaccine Related
|
NIAID
|
5U01AI069403-02
|
|
Harvard Tanzania HIV/AIDS Clinical Trials Unit
|
FAWZI, WAFAIE
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$209,521
|
|
Vaccine Related
|
NIAID
|
5R01AI042075-08
|
|
T cell subsets in murine mycoplasma respiratory disease
|
SIMECKA, JERRY
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$202,894
|
|
Vaccine Related
|
NCI
|
5R01CA104757-04
|
|
Enhancement of HER-2/neu-based therapy using HSP110
|
MANJILI, MASOUD
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$223,222
|
|
Vaccine Related
|
NIA
|
2P01AG000538-29A1
|
0022
|
DIVERSITY OF AMYLOID OLIGOMER ASSEMBLY STATES AND ROLES IN AD PATHOGENESIS
|
GLABE, CHARLES
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$243,643
|
|
Vaccine Related
|
NIAID
|
5F32AI068324-02
|
|
Genomic Approach to Vaccine Design for Proteus mirabilis
|
PEARSON, MELANIE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$51,278
|
|
Vaccine Related
|
NIAID
|
5R01AI057490-05
|
|
Mechanisms and Consequences of Toll Like Receptor Signal Transduction
|
VOGEL, STEFANIE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$241,727
|
|
Vaccine Related
|
NIGMS
|
5U01GM076499-03
|
|
Computational Models of Pathogen Evolution and Vaccinat*
|
BUSH, ROBIN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$296,155
|
|
Vaccine Related
|
NIAID
|
5R01AI064430-04
|
|
Development of a Novel Strategy of Adjuvant Discovery
|
RUSSELL, DAVID
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$396,434
|
|
Vaccine Related
|
NIAID
|
5K02AI073101-02
|
|
Lentivirus Control by CTL and Neutralizing Antibody
|
MEALEY, ROBERT
|
WASHINGTON STATE UNIVERSITY
|
WA
|
$142,020
|
|
Vaccine Related
|
NCI
|
5R01CA102352-04
|
|
PET Imaging of Tumor Targeting & Role of T Lymphocytes
|
PONOMAREV, VLADIMIR
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$341,948
|
|
Vaccine Related
|
NIAID
|
5R01AI058707-04
|
|
Nasal SIV vaccination in female macaques/AIDS prevention
|
ALDOVINI, ANNA
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$592,970
|
|
Vaccine Related
|
NIAID
|
5R01AI068497-02
|
|
The impact of CD8 T cells on viral control and evolution in HIV-infected infants
|
FEENEY, MARGARET
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$412,756
|
|
Vaccine Related
|
NIAID
|
5R01AI067073-03
|
|
Pathogenesis of Clade C HIV Infection
|
WALKER, BRUCE
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$573,658
|
|
Vaccine Related
|
NIAID
|
5R21AI065476-02
|
|
Protective Activity of a Multi-Functional Immunogen
|
GOSSELIN, EDMUND
|
ALBANY MEDICAL COLLEGE
|
NY
|
$224,481
|
|
Vaccine Related
|
NCI
|
5R01CA120956-02
|
|
Enhancing the efficacy of CD19-specific cord blood-derived T Cells
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$292,600
|
|
Vaccine Related
|
NIAID
|
5U01AI056270-05
|
|
Malaria transmission and immunity in highland Kenya
|
JOHN, CHANDY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$588,686
|
|
Vaccine Related
|
NIAID
|
5R01AI059667-05
|
|
Type I Interferons in Immunity to Tuberculosis
|
ERNST, JOEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$392,994
|
|
Vaccine Related
|
NICHD
|
5R01HD038416-08
|
|
Vaccines for Prevention of Experimental Congenital CMV
|
SCHLEISS, MARK
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$252,706
|
|
Vaccine Related
|
NIAID
|
5R01AI067391-02
|
|
Protein Interactions Involved in Orthopoxvirus Envelopment
|
WARD, BRIAN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$339,917
|
|
Vaccine Related
|
NIAID
|
5R01AI046653-08
|
|
Accelerated CD8 T cell memory after DC vaccination
|
HARTY, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$400,429
|
|
Vaccine Related
|
NIEHS
|
5R01ES012199-05
|
|
Epidemiology of Immunotoxicant Exposure in Children
|
GRANDJEAN, PHILIPPE
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$274,955
|
|
Vaccine Related
|
NIAID
|
5R01AI064576-05
|
|
Immunogenicity of Listeria-derived antigens
|
SIJTS, ALICE
|
UNIVERSITY OF UTRECHT
|
NETH
|
$200,916
|
|
Vaccine Related
|
NEI
|
5R01EY016195-02
|
|
Streptococcus pneumoniae ocular pathogenesis and therapy
|
MARQUART, MARY
|
UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
|
MS
|
$329,162
|
|
Vaccine Related
|
NIAID
|
5R01AI062989-04
|
|
Computer Simulation of Epstein Barr Virus Infection
|
THORLEY-LAWSON, DAVID
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$440,562
|
|
Vaccine Related
|
NIAID
|
1R01AI076499-01
|
|
Regulation of memory CD8+ T cell recruitment to the lung
|
WOODLAND, DAVID
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$445,000
|
|
Vaccine Related
|
NCI
|
5R01CA112198-04
|
|
Melanoma Vaccines with Peptides, Protein and Adjuvant
|
ZAROUR, HASSANE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$324,109
|
|
Vaccine Related
|
NHLBI
|
5R01HL086559-02
|
|
Development of a Vaccine Approach to Inhibit Atherosclerosis
|
WITZTUM, JOSEPH
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$386,250
|
|
Vaccine Related
|
NCI
|
5R01CA107243-05
|
|
TLR-mediated DC activation and immune reconstitution
|
HU, HONG-MING
|
PROVIDENCE PORTLAND MEDICAL CENTER
|
OR
|
$248,938
|
|
Vaccine Related
|
NCCAM
|
1R01AT004435-01
|
|
Sublingual Immunotherapy for Peanut Allergy
|
BURKS, ARVIL
|
DUKE UNIVERSITY
|
NC
|
$400,575
|
|
Vaccine Related
|
NIAID
|
5R01AI041123-07
|
|
Mucosal Immunity Elicited by Salmonella Vaccine Delivery
|
PASCUAL, DAVID
|
MONTANA STATE UNIVERSITY (BOZEMAN)
|
MT
|
$296,143
|
|
Vaccine Related
|
NIAID
|
5R01AI055461-05
|
|
HIV and SIV Envelope Glycoproteins
|
ROUX, KENNETH
|
FLORIDA STATE UNIVERSITY
|
FL
|
$354,025
|
|
Vaccine Related
|
NIAID
|
5R01AI044373-09
|
|
Human T Cell Antigens of Mycobacterium tuberculosis
|
REED, STEVEN
|
INFECTIOUS DISEASE RESEARCH INSTITUTE
|
WA
|
$470,628
|
|
Vaccine Related
|
NIAID
|
5U01AI069486-02
|
|
Development of HIV Vaccine Clinical Trials Phase I-II-III in Dominican Republic
|
DONASTORG, YEYCY
|
INSTITUTO DERMATOLOGICO CIRUGIA DE PIEL
|
DOM RE
|
$431,562
|
|
Vaccine Related
|
NIAID
|
5U01AI069477-02
|
|
Miami HIV/AIDS Clinical Therapeutic and Vaccine Trial Unit
|
FISCHL, MARGARET
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$1,354,347
|
|
Vaccine Related
|
NCI
|
5R01CA120776-03
|
|
Memory CD8 T Cell Survival and Function Following Experimental BMT
|
LEVY, ROBERT
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$301,357
|
|
Vaccine Related
|
NCI
|
5R01CA102282-05
|
|
Proteasome inhibitor (PS-341) and adoptive immunotherapy
|
MURPHY, WILLIAM
|
UNIVERSITY OF NEVADA RENO
|
NV
|
$253,662
|
|
Vaccine Related
|
NIAID
|
5U01AI069464-02
|
|
Quintiles Clinical Trial Unit for HIV/AIDS Clinical Trials Networks
|
SQUIRES, KATHLEEN
|
QUINTILES FEDERATED SERVICES, INC.
|
NC
|
$946,844
|
|
Vaccine Related
|
NIAID
|
5U01AI069501-02
|
|
Case AIDS Clinical Trials Unit
|
LEDERMAN, MICHAEL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$2,412,522
|
|
Vaccine Related
|
OD
|
5U01AI069501-02
|
|
Case AIDS Clinical Trials Unit
|
LEDERMAN, MICHAEL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$138,114
|
|
Vaccine Related
|
NIAID
|
5U01AI069451-02
|
|
University of Miami Pediatric Perinatal HIV/AIDS Clinical Trails Unit
|
SCOTT, GWENDOLYN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$1,012,788
|
|
Vaccine Related
|
NCI
|
5R01CA117254-03
|
|
Rescuing CTL from Activation Induced Death
|
MUKHERJI, BIJAY
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$255,082
|
|
Vaccine Related
|
NIAID
|
5R01AI063520-02
|
|
Immunopathology mediated by RSV-specific CD4 T cells
|
VARGA, STEVEN
|
UNIVERSITY OF IOWA
|
IA
|
$356,502
|
|
Vaccine Related
|
NIAID
|
5U01AI069453-02
|
|
Soweto Clinical Trials Unit
|
MCINTYRE, JAMES
|
WITS HEALTH CONSORTIUM (PTY), LTD
|
SO AFR
|
$2,645,148
|
|
Vaccine Related
|
NIGMS
|
5R01GM079804-02
|
|
Computational Assembly of Beta Barrel Membrane Protein
|
LIANG, JIE
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$274,324
|
|
Vaccine Related
|
NHLBI
|
1R21HL091268-01
|
|
Fc receptor targeted therapy for immune hemolytic anemia
|
SELVARAJ, PERIASAMY
|
EMORY UNIVERSITY
|
GA
|
$232,000
|
|
Vaccine Related
|
NIAID
|
1K08AI076351-01
|
|
Characterization of the phagosome during Mycobacterium tuberculosis infection
|
NOLT, DAWN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$130,275
|
|
Vaccine Related
|
NCI
|
5R01CA116444-03
|
|
Mechanism of Eliciting Antitumor Cell Immunity Via Lentivector Immunization
|
HE, YUKAI
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$279,300
|
|
Vaccine Related
|
NIAID
|
1K99AI076346-01
|
|
Preventing and Curing Persistent Infections with Transient FTY720 Treatment
|
PREMENKO-LANIER, MARY
|
EMORY UNIVERSITY
|
GA
|
$87,815
|
|
Vaccine Related
|
NIAID
|
5R37AI038382-14
|
|
HPV CAPSID ANTIBODIES
|
GALLOWAY, DENISE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$316,257
|
|
Vaccine Related
|
NIAID
|
5R01AI067518-03
|
|
Maternal flu infection and brain development in primates
|
COE, CHRISTOPHER
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$426,887
|
|
Vaccine Related
|
NIAID
|
1R21AI076700-01
|
|
Priming of Antifungal T-Cells at Mucosal and Systemic Sites
|
WUETHRICH, MARCEL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$183,750
|
|
Vaccine Related
|
NIAID
|
5R03AI067001-02
|
|
Molecular epidemiology/HIV/STD patients/IVDUs/India
|
PARANJAPE, RAMESH
|
NATIONAL AIDS RESEARCH INSTITUTE
|
INDIA
|
$52,974
|
|
Vaccine Related
|
NCI
|
5R01CA114536-04
|
|
Strategies to Enhance Adoptive Transfer T Cell Clones
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$386,144
|
|
Vaccine Related
|
NIAID
|
5U01AI069438-02
|
|
THE IMPACTA PERU CLINICAL TRIALS UNIT
|
SANCHEZ, JORGE
|
ASOCIACION CIVIL IMPACTA SALUD Y EDUCACN
|
PERU
|
$2,165,121
|
|
Vaccine Related
|
NCI
|
5R21CA124457-02
|
|
Non-invasive imaging of tumor-reactive T cell subsets in vivo
|
DUBEY, PURNIMA
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$177,600
|
|
Vaccine Related
|
NCI
|
5R01CA121180-03
|
|
A Comprehensive Investigation of Viral-induced Lymphomagenesis
|
FISHER, SUSAN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$267,494
|
|
Vaccine Related
|
NIAID
|
1R21AI076706-01
|
|
Impact of NK Cell Immune Pressures on HCV Evolution and Viral Fitness
|
ALTFELD, MARCUS
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$263,250
|
|
Vaccine Related
|
NCI
|
5R21CA114978-02
|
|
A Therapeutic Vaccine for HPV 16-Positive Head and Neck Cancer
|
GILLISON, MAURA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$265,009
|
|
Vaccine Related
|
NCI
|
5R01CA115751-03
|
|
Fra-1: A new target for a genomic breast cancer vaccine
|
REISFELD, RALPH
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$326,609
|
|
Vaccine Related
|
NINDS
|
5R01NS034239-14
|
|
Neuroprotective immunity and HIV dementia
|
GENDELMAN, HOWARD
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$367,500
|
|
Vaccine Related
|
NIAID
|
5R37AI026170-20
|
|
Molecular Genetic Analysis of Mycobacterium tuberculosis
|
JACOBS, WILLIAM
|
YESHIVA UNIVERSITY
|
NY
|
$419,399
|
|
Vaccine Related
|
NCI
|
1R21CA132891-01
|
|
Effect on IL-2R Antibody on Regulatory T-cells in Patients with Malignant Gliomas
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
NC
|
$210,600
|
|
Vaccine Related
|
NCI
|
1K01CA131487-01
|
|
aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy
|
WEBB, TONYA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$119,880
|
|
Vaccine Related
|
NIAID
|
5R13AI068352-03
|
|
HIV Pathogenesis
|
ROBERTSON, ANDREW
|
KEYSTONE SYMPOSIA
|
CO
|
$29,430
|
|
Vaccine Related
|
NIGMS
|
1R21GM076368-01A2
|
|
Nanoparticle Analysis of Enveloped Virus Entry Pathways
|
DAVEY, ROBERT
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$226,500
|
|
Vaccine Related
|
NCI
|
5R01CA114425-04
|
|
ENHANCING HPV-16 E6-SPECIFIC ANTITUMOR IMMUNITY
|
WU, T.-C.
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$307,116
|
|
Vaccine Related
|
NIAID
|
1R01AI076852-01
|
|
Receptor Decoy Inhibitor of Anthrax Toxin
|
YOUNG, JOHN
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
CA
|
$496,525
|
|
Vaccine Related
|
NIGMS
|
1R15GM083261-01
|
|
Synthesis of Various C-Linked Glycopeptides of Biomedical Interest
|
NOLEN, ERNEST
|
COLGATE UNIVERSITY
|
NY
|
$206,810
|
|
Vaccine Related
|
NIAID
|
2R01AI011822-34A1
|
|
Properties of streptococcal M protein
|
FISCHETTI, VINCENT
|
ROCKEFELLER UNIVERSITY
|
NY
|
$420,000
|
|
Vaccine Related
|
NCI
|
5R01CA108813-03
|
|
In Vivo Targeted Vaccines for Tumor Immunotherapy
|
YOU, ZHAOYANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$278,672
|
|
Vaccine Related
|
NINDS
|
5R21NS054781-02
|
|
Development of De-immunized Botulinum Neurotoxin Type A for Dystonia
|
DE GROOT, ANNE
|
EPIVAX, INC.
|
RI
|
$183,750
|
|
Vaccine Related
|
NCI
|
5R01CA115880-03
|
|
Tumor-induced immune suppression.
|
OSTRAND-ROSENBERG, SUZANNE
|
UNIVERSITY OF MARYLAND BALT CO CAMPUS
|
MD
|
$253,359
|
|
Vaccine Related
|
NIDCD
|
5R01DC008671-02
|
|
NTHi Immunity in Young Children
|
PICHICHERO, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$468,167
|
|
